Evaluation of membrane type 1 metalloproteinase (MT1-MMP/MMP14) expression as a prognostic biomarker in patients with solid tumours screened for a Phase I/II trial. (October 2022) - Peters, N.; Morley, H.; Khalique, S.; Scalzo, S.; Patel, R.; Gunaydin, U.; Funingana, G.; Evans, J.; Papadatos-Pastos, D.; Banjeri, U.; Basu, B.; Niewiarowski, A.; et al.